Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200486 · ClinicalTrials.gov registry record
Molecular and Genomic Profiling of Head and Neck Tumors
A clinical trial of Head and Neck Neoplasms, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT00200486: Recruiting study of Head and Neck Neoplasms, sponsored by Montefiore Medical Center.
NCT00200486 is a study of Head and Neck Neoplasms that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 1,000 participants, above the 222-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (350% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00200486, a study of Head and Neck Neoplasms, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to study the genetic profile of head and neck tumors and their relationship to treatment response and outcome
Conditions Studied
Study Locations (1)
New York
- Stelby Augustine - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2002-10-01 |
| Est. Completion | 2030-12 |
What NCT00200486 shows while recruiting
NCT00200486 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 222-participant average among 23 other Head and Neck Neoplasms trials with a reported enrollment target (350% higher).
The record links to 1 condition, with Head and Neck Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT00200486 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00200486 about?
NCT00200486 is a clinical study titled "Molecular and Genomic Profiling of Head and Neck Tumors". The purpose of this study is to study the genetic profile of head and neck tumors and their relationship to treatment response and outcome
What is the current status of trial NCT00200486?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2002-10-01. Estimated completion is 2030-12.
What conditions does trial NCT00200486 study?
This clinical trial studies the following conditions: Head and Neck Neoplasms.
Who is sponsoring clinical trial NCT00200486?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00200486 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00200486's enrollment target sits among peer trials
1,000 1st of 23 higher than 21 of 23 other Head and Neck Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Head and Neck Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMST in Patients Undergoing CRT for HNCA
RECRUITING · NA
-
Head and Neck Cancer Study Project in the Geriatric Population
RECRUITING · Phase 3
-
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
RECRUITING
-
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
RECRUITING · Phase 2
-
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
RECRUITING · Phase 1
-
Biospecimen Procurement for Head and Neck Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI